Fundz

Drug discovery startup Peptris raises Rs 70 crore in a Series A funding round co-led by IAN Alpha Fund and Speciale Invest to advance its drug development efforts.

PRIVATEFeb 21, 2026

Amount Raised

$7.7 Million

Round Type

Series A

BengaluruBiotechnologyArtificial IntelligenceTherapeuticsPharmaceutical

Investors

Tenacity VenturesByt VenturesIAN Alpha FundSpeciale Invest

Description

Bengaluru-based drug discovery startup Peptris has raised Rs 70 crore, about $7.7 million, in a Series A funding round. The round was co-led by IAN Alpha Fund and Speciale Invest, with participation from other investors. The fresh capital will be used to advance its lead programmes toward clinical readiness and expand its discovery pipeline. Peptris aims to improve drug discovery processes through advanced AI models.

Quick answer

Peptis raised $7.7 Million in a Series A round, dated February 21, 2026. Investors: Tenacity Ventures, Byt Ventures, IAN Alpha Fund and Speciale Invest. Peptis is based in Bengaluru, Karnataka, India.

How much did Peptis raise?
Peptis raised $7.7 Million in a Series A round on February 21, 2026.
Who invested in Peptis?
Tenacity Ventures, Byt Ventures, IAN Alpha Fund and Speciale Invest are named as investors in this round.
What does Peptis do?
Peptris is a Bengaluru-based drug discovery startup founded in 2019 that leverages AI models to generate novel molecules and predict critical parameters for drug development.
Where is Peptis based and how big is it?
Peptis is based in Bengaluru, Karnataka, India.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Peptis that raised within 45 days of this round, from Fundz verified event records.

  • Acurion raised $4.3M (Seed) on March 17, 2026.
  • Os Therapies raised $2M on March 4, 2026.
  • Change Agents Corporation. raised $207K (Debt Financing) on February 25, 2026.
  • Pharmacelera raised $7.1M on February 18, 2026.
  • Nasus Pharma raised $15M on February 10, 2026.
  • Os Therapies raised $3.5M on January 14, 2026.

Who to call at Peptis, and when

A new round usually means Peptis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Peptis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Peptis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Peptis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Peptis

Location

Bengaluru, Karnataka, India

About

Peptris is a Bengaluru-based drug discovery startup founded in 2019 that leverages AI models to generate novel molecules and predict critical parameters for drug development. Its platform aims to enhance decision-making in the early stages of research, reducing the risks and failure rates associated with drug discovery. The company focuses on improving candidate selection and optimization to overcome challenges in the pre-clinical stage. Peptris is advancing multiple new NCE programmes and drug repurposing initiatives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Peptis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Peptis's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Peptis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.